What it is
Noopept (N-Phenylacetyl-L-prolylglycine ethyl ester) is a synthetic dipeptide nootropic developed in Russia in 1996. It is a prodrug of cycloprolylglycine, an endogenous neuropeptide. Unlike racetams, Noopept is active at microgram doses (10–30mg) and has demonstrated neuroprotective, anxiolytic, and cognitive-enhancing effects in Russian clinical trials.